{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:01:57Z","timestamp":1790935317826,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":52,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Ministry of Economy and Competitiveness | Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI22\/00947"],"award-info":[{"award-number":["PI22\/00947"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Ministry of Economy and Competitiveness | Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI23\/00488"],"award-info":[{"award-number":["PI23\/00488"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Ministry of Economy and Competitiveness | Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CP22\/00005"],"award-info":[{"award-number":["CP22\/00005"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003425","name":"Departamento de Educaci\u00f3n, Gobierno de Navarra","doi-asserted-by":"publisher","award":["GNS_44-2021, 0011-1411-2022-000077 (NANO-RC), NANO-Protacs"],"award-info":[{"award-number":["GNS_44-2021, 0011-1411-2022-000077 (NANO-RC), NANO-Protacs"]}],"id":[{"id":"10.13039\/501100003425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003425","name":"Departamento de Educaci\u00f3n, Gobierno de Navarra","doi-asserted-by":"publisher","award":["GN2023\/11"],"award-info":[{"award-number":["GN2023\/11"]}],"id":[{"id":"10.13039\/501100003425","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer J."],"DOI":"10.1038\/s41408-026-01604-w","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T09:23:30Z","timestamp":1786440210000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A myeloid-dormant metabolic transcriptome identifies a poor-prognosis subgroup in hyperdiploid multiple myeloma with targetable vulnerabilities"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4324-3371","authenticated-orcid":false,"given":"Naroa","family":"Barrena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5786-5273","authenticated-orcid":false,"given":"Edurne","family":"San Jos\u00e9-En\u00e9riz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis V.","family":"Valc\u00e1rcel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1740-6616","authenticated-orcid":false,"given":"Danel","family":"Olaverri-Mendizabal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estibaliz","family":"Urizar-Compains","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leire","family":"Garate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Est\u00edbaliz","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9812-396X","authenticated-orcid":false,"given":"Paula","family":"Rodriguez-Marquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romika","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1483-4279","authenticated-orcid":false,"given":"Patxi","family":"San Mart\u00edn-Uriz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Roberto","family":"Rodriguez-Madoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0340-7458","authenticated-orcid":false,"given":"Leonor","family":"Puchades-Carrasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4324-8706","authenticated-orcid":false,"given":"Caroline A.","family":"Heckman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5236-7785","authenticated-orcid":false,"given":"Paula","family":"Rodriguez-Otero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1155-3105","authenticated-orcid":false,"given":"Francisco J.","family":"Planes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6558-9560","authenticated-orcid":false,"given":"Xabier","family":"Agirre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6115-8790","authenticated-orcid":false,"given":"Felipe","family":"Pr\u00f3sper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"key":"1604_CR1","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/S0140-6736(19)32956-3","volume":"395","author":"MV Mateos","year":"2020","unstructured":"Mateos MV, Cavo M, Blade J, Dimopoulos MA, Suzuki K, Jakubowiak A, et al. Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial. Lancet. 2020;395:132\u201341.","journal-title":"Lancet"},{"key":"1604_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cells10020336","volume":"10","author":"IJ Cardona-benavides","year":"2021","unstructured":"Cardona-benavides IJ, de Ram\u00f3n C, Guti\u00e9rrez NC. Genetic abnormalities in multiple myeloma: Prognostic and therapeutic implications. Cells. 2021;10:1\u201328.","journal-title":"Cells"},{"key":"1604_CR3","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.ccell.2015.10.014","volume":"28","author":"E Braggio","year":"2015","unstructured":"Braggio E, Kort\u00fcm KM, Stewart AK. SnapShot: multiple myeloma. Cancer Cell. 2015;28:678\u2013678.e1.","journal-title":"Cancer Cell"},{"key":"1604_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12:31\u201346.","journal-title":"Cancer Discov"},{"key":"1604_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms6469","volume":"5","author":"L Li","year":"2014","unstructured":"Li L, Wei Y, To C, Zhu CQ, Tong J, Pham NA, et al. Integrated Omic analysis of lung cancer reveals metabolism proteome signatures with prognostic impact. Nat Commun. 2014;5:1\u201312.","journal-title":"Nat Commun"},{"key":"1604_CR6","doi-asserted-by":"publisher","first-page":"3263","DOI":"10.1158\/1078-0432.CCR-14-1200","volume":"21","author":"P Korangath","year":"2015","unstructured":"Korangath P, Teo WW, Sadik H, Han L, Mori N, Huijts CM, et al. Targeting glutamine metabolism in breast cancer with aminooxyacetate. Clin Cancer Res. 2015;21:3263\u201373.","journal-title":"Clin Cancer Res"},{"key":"1604_CR7","doi-asserted-by":"publisher","first-page":"246811","DOI":"10.3389\/fphys.2017.00097","volume":"8","author":"F Cutruzzol\u00e0","year":"2017","unstructured":"Cutruzzol\u00e0 F, Giardina G, Marani M, Macone A, Paiardini A, Rinaldo S, et al. Glucose metabolism in the progression of prostate cancer. Front Physiol. 2017;8:246811.","journal-title":"Front Physiol"},{"key":"1604_CR8","first-page":"2261","volume":"9","author":"M Liu","year":"2021","unstructured":"Liu M, Wang Y, Miettinen JJ, Kumari R, Majumder MM, Tierney C, et al. S100 calcium binding protein family members associate with poor patient outcome and response to proteasome inhibition in multiple myeloma. Front Cell Dev Biol. 2021;9:2261.","journal-title":"Front Cell Dev Biol"},{"key":"1604_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-024-45350-8","volume":"15","author":"N Thongon","year":"2024","unstructured":"Thongon N, Ma F, Baran N, Lockyer P, Liu J, Jackson C, et al. Targeting DNA2 overcomes metabolic reprogramming in multiple myeloma. Nat Commun. 2024;15:1\u201313.","journal-title":"Nat Commun"},{"key":"1604_CR10","doi-asserted-by":"publisher","unstructured":"Agirre X, Meydan C, Jiang Y, Garate L, Doane AS, Li Z, et al. Long non-coding RNAs discriminate the stages and gene regulatory states of human humoral immune response. Nat Commun 2019; 10. https:\/\/doi.org\/10.1038\/s41467-019-08679-z.","DOI":"10.1038\/s41467-019-08679-z"},{"key":"1604_CR11","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1038\/s41375-021-01147-y","volume":"35","author":"A Carrasco-Leon","year":"2021","unstructured":"Carrasco-Leon A, Ezponda T, Meydan C, Valc\u00e1rcel LV, Ordo\u00f1ez R, Kulis M, et al. Characterization of complete lncRNAs transcriptome reveals the functional and clinical impact of lncRNAs in multiple myeloma. Leukemia. 2021;35:1438\u201350.","journal-title":"Leukemia"},{"key":"1604_CR12","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1182\/blood-2009-12-261032","volume":"116","author":"A Broyl","year":"2010","unstructured":"Broyl A, Hose D, Lokhorst H, De Knegt Y, Peeters J, Jauch A, et al. Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patients. Blood. 2010;116:2543\u201353.","journal-title":"Blood"},{"key":"1604_CR13","unstructured":"Bengtsson H, Simpson K, Bullard J, Hansen K aroma.affymetrix: A generic framework in R for analyzing small to very large Affymetrix data sets in bounded memory. Methods 2008; Tech Repor: 1\u20139."},{"key":"1604_CR14","doi-asserted-by":"publisher","unstructured":"Possemato R, Marks KM, Shaul YD, Pacold ME, Kim D, Birsoy K et al. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. 2011. https:\/\/doi.org\/10.1038\/nature10350.","DOI":"10.1038\/nature10350"},{"key":"1604_CR15","first-page":"199","volume":"7","author":"J Wang","year":"2009","unstructured":"Wang J, Wen S, Fraser Symmans W, Pusztai L, Coombes KR. The bimodality index: A criterion for discovering and ranking bimodal signatures from cancer gene expression profiling data. Cancer Inf. 2009;7:199\u2013216.","journal-title":"Cancer Inf"},{"key":"1604_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-11-367","volume":"11","author":"R Gaujoux","year":"2010","unstructured":"Gaujoux R, Seoighe C. A flexible R package for nonnegative matrix factorization. BMC Bioinforma. 2010;11:1\u20139.","journal-title":"BMC Bioinforma"},{"key":"1604_CR17","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","volume":"27","author":"A Liberzon","year":"2011","unstructured":"Liberzon A, Subramanian A, Pinchback R, Thorvaldsd\u00f3ttir H, Tamayo P, Mesirov JP. Molecular signatures database (MSigDB) 3.0. Bioinformatics. 2011;27:1739\u201340.","journal-title":"Bioinformatics"},{"key":"1604_CR18","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102:15545\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1604_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: Gene set variation analysis for microarray and RNA-Seq data. BMC Bioinforma. 2013;14:1\u201315.","journal-title":"BMC Bioinforma"},{"key":"1604_CR20","doi-asserted-by":"publisher","unstructured":"Ainciburu M, Ezponda T, Berastegui N, Alfonso-Pierola A, Vilas-Zornoza A, Martin-Uriz PS et al. Uncovering perturbations in human hematopoiesis associated with healthy aging and myeloid malignancies at single-cell resolution. Elife 2023; 12. https:\/\/doi.org\/10.7554\/eLife.79363.","DOI":"10.7554\/eLife.79363"},{"key":"1604_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-020-00941-y","volume":"13","author":"J Wu","year":"2020","unstructured":"Wu J, Xiao Y, Sun J, Sun H, Chen H, Zhu Y, et al. A single-cell survey of cellular hierarchy in acute myeloid leukemia. J Hematol Oncol. 2020;13:1\u201319.","journal-title":"J Hematol Oncol"},{"key":"1604_CR22","unstructured":"De La Fuente Cede\u00f1o J, Hernaez M, Blatti C TraRe: Transcriptional Rewiring. 2022.https:\/\/github.com\/ubioinformat\/TraRe\/tree\/master."},{"key":"1604_CR23","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.cell.2018.01.029","volume":"172","author":"SA Lambert","year":"2018","unstructured":"Lambert SA, Jolma A, Campitelli LF, Das PK, Yin Y, Albu M, et al. The Human Transcription Factors. Cell. 2018;172:650\u201365.","journal-title":"Cell."},{"key":"1604_CR24","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1126\/sciadv.abo0514","volume":"8","author":"P Rodriguez-Marquez","year":"2022","unstructured":"Rodriguez-Marquez P, Calleja-Cervantes ME, Serrano G, Oliver-Caldes A, Palacios-Berraquero ML, Martin-Mallo A, et al. CAR density influences antitumoral efficacy of BCMA CAR T cells and correlates with clinical outcome. Sci Adv. 2022;8:514.","journal-title":"Sci Adv"},{"key":"1604_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.omton.2025.200949","volume":"33","author":"F Bernasconi-Bisio","year":"2025","unstructured":"Bernasconi-Bisio F, Molina E, Ibarra V, Ib\u00e1\u00f1ez-Sala I, Rochira F, Jauregui P, et al. Discovery and preclinical development of a SdAb-based CAR-T technology for targeting CD33 in AML. Mol Ther Oncol. 2025;33:200949.","journal-title":"Mol Ther Oncol"},{"key":"1604_CR26","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1101\/gr.265520.120","volume":"30","author":"R Ordo\u00f1ez","year":"2020","unstructured":"Ordo\u00f1ez R, Kulis M, Russi\u00f1ol N, Chapaprieta V, Carrasco-Leon A, Garc\u00eda-Torre B, et al. Chromatin activation as a unifying principle underlying pathogenic mechanisms in multiple myeloma. Genome Res. 2020;30:1217\u201327.","journal-title":"Genome Res"},{"key":"1604_CR27","doi-asserted-by":"publisher","unstructured":"Zhang Y, Parmigiani G, Johnson WE. ComBat-seq: Batch effect adjustment for RNA-seq count data. NAR Genomics Bioinforma 2020; 2. https:\/\/doi.org\/10.1093\/nargab\/lqaa078.","DOI":"10.1093\/nargab\/lqaa078"},{"key":"1604_CR28","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1200\/JCO.2015.61.2267","volume":"33","author":"A Palumbo","year":"2015","unstructured":"Palumbo A, Avet-Loiseau H, Oliva S, Lokhorst HM, Goldschmidt H, Rosinol L, et al. Revised international staging system for multiple myeloma: A report from the International Myeloma Working Group. J Clin Oncol. 2015;33:2863\u20139.","journal-title":"J Clin Oncol"},{"key":"1604_CR29","doi-asserted-by":"publisher","unstructured":"Avet-Loiseau H, Davies FE, Samur MK, Corre J, D\u2019agostino M, Kaiser MF et al. International Myeloma Society\/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma. J Clin Oncol 2025. https:\/\/doi.org\/10.1200\/JCO-24-01893\/SUPPL_FILE\/DS_JCO-24-01893.PDF.","DOI":"10.1200\/JCO-24-01893\/SUPPL_FILE\/DS_JCO-24-01893.PDF"},{"key":"1604_CR30","doi-asserted-by":"publisher","unstructured":"Bailur JK, McCachren SS, Doxie DB, Shrestha M, Pendleton K, Nooka AK et al. Early alterations in stem-like\/marrow-resident T cells and innate and myeloid cells in preneoplastic gammopathy. JCI Insight 2019; 4. https:\/\/doi.org\/10.1172\/jci.insight.127807.","DOI":"10.1172\/jci.insight.127807"},{"key":"1604_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48327-9","volume":"15","author":"TS Johnson","year":"2024","unstructured":"Johnson TS, Sudha P, Liu E, Becker N, Robertson S, Blaney P, et al. 1q amplification and PHF19 expressing high-risk cells are associated with relapsed\/refractory multiple myeloma. Nat Commun. 2024;15:4144.","journal-title":"Nat Commun"},{"key":"1604_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22804-x","volume":"12","author":"R Liu","year":"2021","unstructured":"Liu R, Gao Q, Foltz SM, Fowles JS, Yao L, Wang JT, et al. Co-evolution of tumor and immune cells during progression of multiple myeloma. Nat Commun. 2021;12:2559.","journal-title":"Nat Commun"},{"key":"1604_CR33","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1038\/s43018-023-00657-1","volume":"4","author":"F Maura","year":"2023","unstructured":"Maura F, Boyle EM, Coffey D, Maclachlan K, Gagler D, Diamond B, et al. Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimens. Nat Cancer. 2023;4:1660\u201374.","journal-title":"Nat Cancer"},{"key":"1604_CR34","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1182\/blood.2018880930","volume":"134","author":"WH Khoo","year":"2019","unstructured":"Khoo WH, Ledergor G, Weiner A, Roden DL, Terry RL, McDonald MM, et al. A niche-dependent myeloid transcriptome signature defines dormant myeloma cells. Blood. 2019;134:30\u201343.","journal-title":"Blood"},{"key":"1604_CR35","doi-asserted-by":"publisher","unstructured":"Shim H, Ha JH, Lee H, Sohn JY, Kim HJ, Eom HS, et al. Expression of Myeloid Antigen in Neoplastic Plasma Cells Is Related to Adverse Prognosis in Patients with Multiple Myeloma. Biomed Res Int 2014; 2014. https:\/\/doi.org\/10.1155\/2014\/893243.","DOI":"10.1155\/2014\/893243"},{"key":"1604_CR36","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1093\/jnci\/94.13.1020","volume":"94","author":"Y Mishima","year":"2002","unstructured":"Mishima Y, Matsumoto-Mishima Y, Terui Y, Katsuyama M, Yamada M, Mori M, et al. Leukemic cell-surface CD13\/aminopeptidase N and resistance to apoptosis mediated by endothelial cells. J Natl Cancer Inst. 2002;94:1020\u20138.","journal-title":"J Natl Cancer Inst"},{"key":"1604_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1270843","volume":"14","author":"C Calvi\u00f1o","year":"2023","unstructured":"Calvi\u00f1o C, Ceballos C, Alfonso A, Jauregui P, Calleja-Cervantes ME, San Martin-Uriz P, et al. Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemia. Front Immunol. 2023;14:1270843.","journal-title":"Front Immunol"},{"key":"1604_CR38","doi-asserted-by":"crossref","unstructured":"Altea-Manzano P, Decker-Farrell A, Janowitz T, Erez A. Metabolic interplays between the tumour and the host shape the tumour macroenvironment. Nat Rev Cancer 2025; 1\u201319.","DOI":"10.1038\/s41568-024-00786-4"},{"key":"1604_CR39","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.bbalip.2014.03.001","volume":"1841","author":"DS Paul","year":"2014","unstructured":"Paul DS, Grevengoed TJ, Pascual F, Ellis JM, Willis MS, Coleman RA. Deficiency of cardiac Acyl-CoA synthetase-1 induces diastolic dysfunction, but pathologic hypertrophy is reversed by rapamycin. Biochim Biophys Acta - Mol Cell Biol Lipids. 2014;1841:880\u20137.","journal-title":"Biochim Biophys Acta - Mol Cell Biol Lipids"},{"key":"1604_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-71962-7","volume":"14","author":"H Fu","year":"2024","unstructured":"Fu H, Han X, Guo W, Zhao X, Yu C, Zhao W, et al. Cystathionine-\u03b3-lyase contributes to tamoxifen resistance, and the compound I194496 alleviates this effect by inhibiting the PPAR\u03b3\/ACSL1\/STAT3 signalling pathway in oestrogen receptor-positive breast cancer. Sci Rep. 2024;14:22988.","journal-title":"Sci Rep"},{"key":"1604_CR41","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1038\/s41388-021-01667-y","volume":"40","author":"Y Ma","year":"2021","unstructured":"Ma Y, Zha J, Yang XK, Li Q, Zhang Q, Yin A, et al. Long-chain fatty acyl-CoA synthetase 1 promotes prostate cancer progression by elevation of lipogenesis and fatty acid beta-oxidation. Oncogene. 2021;40:1806\u201320.","journal-title":"Oncogene"},{"key":"1604_CR42","doi-asserted-by":"publisher","unstructured":"Murphy CS, Fairfield H, DeMambro VE, Fadel S, Gartner CA, Karam M, et al. Inhibition of acyl-CoA synthetase long-chain isozymes decreases multiple myeloma cell proliferation and causes mitochondrial dysfunction. Mol Oncol 2025. https:\/\/doi.org\/10.1002\/1878-0261.13794.","DOI":"10.1002\/1878-0261.13794"},{"key":"1604_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-15051-z","volume":"11","author":"R Bajpai","year":"2020","unstructured":"Bajpai R, Sharma A, Achreja A, Edgar CL, Wei C, Siddiqa AA, et al. Electron transport chain activity is a predictor and target for venetoclax sensitivity in multiple myeloma. Nat Commun. 2020;11:1\u201316.","journal-title":"Nat Commun"},{"key":"1604_CR44","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1101\/gr.180240.114","volume":"25","author":"X Agirre","year":"2015","unstructured":"Agirre X, Castellano G, Pascual M, Heath S, Kulis M, Segura V, et al. Whole-epigenome analysis in multiple myeloma reveals DNA hypermethylation of B cell-specific enhancers. Genome Res. 2015;25:478\u201387.","journal-title":"Genome Res"},{"key":"1604_CR45","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1200\/JCO.23.01277","volume":"42","author":"F Maura","year":"2024","unstructured":"Maura F, Rajanna AR, Ziccheddu B, Poos AM, Derkach A, MacLachlan K, et al. Genomic classification and individualized prognosis in multiple myeloma. J Clin Oncol. 2024;42:1229\u201340.","journal-title":"J Clin Oncol"},{"key":"1604_CR46","doi-asserted-by":"publisher","first-page":"990","DOI":"10.3390\/biology12070990","volume":"12","author":"JP Capp","year":"2023","unstructured":"Capp JP, Bataille R. The ins and outs of endosteal niche disruption in the bone marrow: relevance for myeloma oncogenesis. Biology. 2023;12:990.","journal-title":"Biology"},{"key":"1604_CR47","doi-asserted-by":"publisher","first-page":"4085","DOI":"10.1007\/s00018-021-03767-0","volume":"78","author":"EV Morris","year":"2021","unstructured":"Morris EV, Edwards CM. Morphogens and growth factor signalling in the myeloma bone-lining niche. Cell Mol Life Sci. 2021;78:4085\u201393.","journal-title":"Cell Mol Life Sci"},{"key":"1604_CR48","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.3390\/cancers16061170","volume":"16","author":"Y Ma","year":"2024","unstructured":"Ma Y, Nenkov M, Berndt A, Abubrig M, Schmidt M, Sandhaus T, et al. The diagnostic value of ACSL1, ACSL4, and ACSL5 and the clinical potential of an ACSL inhibitor in non-small-cell lung cancer. Cancers. 2024;16:1170.","journal-title":"Cancers"},{"key":"1604_CR49","doi-asserted-by":"publisher","first-page":"555","DOI":"10.3390\/biom9100555","volume":"9","author":"R Ahmad","year":"2019","unstructured":"Ahmad R, Thomas R, Al-Rashed F, Akhter N, Al-Mulla F. Acsl1 regulates tnf\u03b1-induced gm-csf production by breast cancer mda-mb-231 cells. Biomolecules. 2019;9:555.","journal-title":"Biomolecules"},{"key":"1604_CR50","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s11684-022-0942-1","volume":"17","author":"W Ye","year":"2023","unstructured":"Ye W, Wang J, Huang J, He X, Ma Z, Li X, et al. ACSL5, a prognostic factor in acute myeloid leukemia, modulates the activity of Wnt\/\u03b2-catenin signaling by palmitoylation modification. Front Med. 2023;17:685\u201398.","journal-title":"Front Med"},{"key":"1604_CR51","doi-asserted-by":"publisher","first-page":"4025","DOI":"10.1182\/bloodadvances.2023012298","volume":"8","author":"S Deng","year":"2024","unstructured":"Deng S, Derebail S, Weiler VJ, Ng JF, Maroto-Martin E, Chatterjee M, et al. Venetoclax resistance leads to broad resistance to standard-of-care anti-MM agents, but not to immunotherapies. Blood Adv. 2024;8:4025\u201334.","journal-title":"Blood Adv"},{"key":"1604_CR52","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1182\/blood.2024025690","volume":"145","author":"R Nair","year":"2025","unstructured":"Nair R, Vu AH, Freer AK, Bhatia KS, Wang D, Savani MR, et al. Heme promotes venetoclax resistance in multiple myeloma through MEK-ERK signaling and purine biosynthesis. Blood. 2025;145:732\u2013747.","journal-title":"Blood"}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41408-026-01604-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-026-01604-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-026-01604-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:47:45Z","timestamp":1790934465000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41408-026-01604-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1604"],"URL":"https:\/\/doi.org\/10.1038\/s41408-026-01604-w","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,11]]},"assertion":[{"value":"3 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"169"}}